subject area of
- A Step Change in Oral Anticoagulation: Lack of Coagulation Monitoring with Ximelagatran Journal Articles
- A new method for measurement of total plasma PCSK9: clinical applications Journal Articles
- A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I Journal Articles
- A review of the oral direct thrombin inhibitor ximelagatran Journal Articles
- Acute reversal of anticoagulant-induced bleeding complications. Journal Articles
- Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Journal Articles
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Journal Articles
- Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer Journal Articles
- Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Journal Articles
- Beyond Unfractionated Heparin and Warfarin Journal Articles
- Clinical trials of new anticoagulants. Journal Articles
- Combination therapy for dyslipidemia Journal Articles
- Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin Journal Articles
- Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation Journal Articles
- Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia Journal Articles
- Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers Journal Articles
- Effects of Ezetimibe Add-on to Statin Therapy on Adipokine Production in Patients With Metabolic Syndrome and Stable Vascular Disease Journal Articles
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes Journal Articles
- In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survival Journal Articles
- Inviting Patients to Read Doctors' Notes Journal Articles
- Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients Journal Articles
- Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma Journal Articles
- New Anticoagulants for Treatment of Venous Thromboembolism Journal Articles
- New anticoagulants Conferences
- Nonbleeding complications of unfractionated and low-molecular weight heparins. Journal Articles
- Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism Journal Articles
- Orally Active Direct Thrombin Inhibitors Journal Articles
- Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosis Journal Articles
- Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents Journal Articles
- Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran Journal Articles
- Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long‐term secondary prevention of venous thromboembolism Journal Articles
- Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism Journal Articles
- Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran Journal Articles
- Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease Journal Articles
- The Role of Ximelagatran in the Treatment of Venous Thromboembolism Journal Articles
- The beginning of the end of warfarin? Journal Articles
- The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model Journal Articles
- The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Journal Articles
- Ximelagatran for Secondary Prevention of Venous Thromboembolism Journal Articles
- Ximelagatran for the secondary prevention of venous thromboembolism Journal Articles
- Ximelagatran in the Clinic: Practical Management of Patients Journal Articles
- Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation? Journal Articles
- Ximelagatran or warfarin in atrial fibrillation? Journal Articles
- Ximelagatran: the first oral direct thrombin inhibitor Journal Articles
- Ximelagatran: the first oral direct thrombin inhibitor. Journal Articles